A carregar...
A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
BACKGROUND: The REFLECT trials were conducted to examine the treatment of mild-to-moderate Alzheimer’s disease utilizing a peroxisome proliferator-activated receptor gamma agonist. OBJECTIVE: To generate a predictive biomarker indicative of positive treatment response using samples from the previous...
Na minha lista:
| Publicado no: | J Alzheimers Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IOS Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203239/ https://ncbi.nlm.nih.gov/pubmed/33814447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-201610 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|